Skip to main content
. 2018 Dec 15;7(12):bio036194. doi: 10.1242/bio.036194

Fig. 1.

Fig. 1.

The verification of the BMSCs and the change of IRS-1, TAZ, RUNX2 and OCN mRNA expression during osteogenic differentiation. (A) The BMSCs were isolated from bone marrow, cultured in vitrol and verified by flow cytometry for hematopoietic surface markers CD34 (0.6%) and CD45 (1.6%), and BMSC surface markers CD29 (100%) and CD90 (96%). (B,C) Passage 3 BMSCs were cultured with growth medium or (C) osteogenic medium for 14 days. (D) Alizarin Red staining was performed and (E) the quantification by cetylpyridinium chloride dissolution was presented after inducing osteogenic medium for 14 days. (F) The mRNA expression of IRS-1, TAZ, RUNX2 and CON in BMSCs cultured in osteogenic medium for 3, 7 and 14 days were measured by fluorogenic quantitative PCR. (s.d.±mean; n=3) *P<0.05 versus control group.